JCR-Journal of Clinical Rheumatology

Papers
(The H4-Index of JCR-Journal of Clinical Rheumatology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors38
The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis24
Let's Talk About Lupus. Overview of an Innovative, High-Reach, Online Program to Fill the Education Gaps of Latin Americans Living With Lupus22
Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis22
Real-World Experience of Tixagevimab and Cilgavimab (Evusheld) in Rheumatologic Patients on Rituximab21
Risk of Cardiovascular and Venous Thromboembolic Events Associated With Janus Kinase Inhibitors in Rheumatoid Arthritis20
Expansion of Phenotypic and Genotypic Spectrum in Yao Syndrome19
International Perspectives on Joint Hypermobility19
IgG4-Related Disease18
Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 201916
Paraneoplastic Arthritides16
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents14
Role of Biological Agents in the Treatment of SARS-CoV-2–Associated Multisystem Inflammatory Syndrome in Children14
A Case of Refractory Interstitial Lung Disease in Anti-MDA5–Positive Dermatomyositis That Improved After Switching to Tofacitinib14
0.061230182647705